LOPEMIN Side Effects

7020333-2 | Abdominal Distension, Abnormal Faeces, Enteritis Infectious, Flatulence, Portal Venous Gas, Shock
on Sep 24, 2010 Male patient from JAPAN , 60 years of age, was diagnosed with diarrhoea, pain (What is pain?), head and neck cancer (What is head and neck cancer?) and was treated with Lopemin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, abnormal faeces, enteritis infectious, flatulence, portal venous gas, shock. Lopemin dosage: . During the same period patient was treated with DUROTEP (View Durotep Review and Durotep Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ).

7000466-7 | Convulsion, Electrolyte Imbalance, Overdose
Patient was taking Lopemin (View Usage). Patient had the following side effects: convulsion, electrolyte imbalance, overdose on Sep 10, 2010 from JAPAN Additional patient health information: Female patient , 89 years of age, was diagnosed with diarrhoea, convulsion and. Lopemin dosage: . During the same period patient was treated with TANNALBIN (View Tannalbin Review and Tannalbin Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ). Patient was hospitalized.

6940789-0 | Convulsion, Electrolyte Imbalance, Overdose
Adverse event was reported on Aug 16, 2010 by a Female patient taking Lopemin (View Usage) (Dosage: ) was diagnosed with diarrhoea and. Location: JAPAN , 89 years of age, After Lopemin was administered, patient had the following side effects: convulsion, electrolyte imbalance, overdose. During the same period patient was treated with PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ), TANNALBIN (View Tannalbin Review and Tannalbin Label ).

6774336-3 | Neutropenia, Rash Erythematous
on Jun 07, 2010 Male patient from JAPAN , weighting 136.7 lb, was diagnosed with diarrhoea, lung neoplasm malignant and was treated with Lopemin (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia, rash erythematous. Lopemin dosage: . During the same period patient was treated with TOPOTECAN (Intermittent) (View Topotecan Review and Topotecan Label ), RANDA (View Randa Review and Randa Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), GASTER D (View Gaster D Review and Gaster D Label ). Patient was hospitalized.


6774334-X | Blood Pressure Increased, Fatigue, Gastric Ileus, Stomatitis, Weight Decreased
on Jun 07, 2010 Female patient from JAPAN , weighting 119.7 lb, was diagnosed with diarrhoea, large intestine carcinoma and was treated with Lopemin (View Usage). Patient had the following side effects: blood pressure increased, fatigue, gastric ileus, stomatitis, weight decreased. Lopemin dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM FOLINATE (200 Mg/m2) (View Calcium Folinate Review and Calcium Folinate Label ), IRINOTECAN (150 Mg/m2) (View Irinotecan Review and Irinotecan Label ), AXITINIB (View Axitinib Review and Axitinib Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ). Patient was hospitalized.

6774333-8 | C-reactive Protein Increased, Diarrhoea, Disseminated Intravascular Coagulation, Gastrointestinal Necrosis, Haematochezia, Intestinal Perforation, Leukopenia, Melaena, Neutropenia
Patient was taking Lopemin (View Usage). After Lopemin was administered, patient had the following side effects: c-reactive protein increased, diarrhoea, disseminated intravascular coagulation, gastrointestinal necrosis, haematochezia, intestinal perforation, leukopenia, melaena, neutropenia on Jun 07, 2010 from JAPAN Additional patient health information: Male patient , weighting 119.0 lb, was diagnosed with diarrhoea, colon cancer and. Lopemin dosage: . During the same period patient was treated with CAMPTOSAR (View Camptosar Review and Camptosar Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), KYTRIL (View Kytril Review and Kytril Label ), DECADRON (View Decadron Review and Decadron Label ), ADALAT (View Adalat Review and Adalat Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ). Patient was hospitalized and became disabled.

6766434-5 | Anaemia, Ileus, Leukopenia, Thrombocytopenia
Adverse event was reported on Jun 03, 2010 by a Male patient taking Lopemin (View Usage) (Dosage: ) was diagnosed with diarrhoea and. Location: JAPAN , weighting 141.1 lb, Patient experienced the following unwanted or unexpected effects: anaemia, ileus, leukopenia, thrombocytopenia. During the same period patient was treated with CAMPTOSAR (View Camptosar Review and Camptosar Label ), ALBUMIN TANNATE (View Albumin Tannate Review and Albumin Tannate Label ), LAC B (View Lac B Review and Lac B Label ), CATLEP (View Catlep Review and Catlep Label ). Patient was hospitalized.

6763980-5 | Hepatic Enzyme Increased, Ileus, Ileus Paralytic, Pyrexia, Small Intestinal Perforation, White Blood Cell Count Increased
on Jun 03, 2010 Female patient from JAPAN , 74 years of age, was diagnosed with diarrhoea, ovarian cancer and was treated with Lopemin (View Usage). Patient had the following side effects: hepatic enzyme increased, ileus, ileus paralytic, pyrexia, small intestinal perforation, white blood cell count increased. Lopemin dosage: . During the same period patient was treated with CAMPTOSAR (100mg/m2, Cyclic) (View Camptosar Review and Camptosar Label ), MITOMYCIN (View Mitomycin Review and Mitomycin Label ).

6589343-3 | Condition Aggravated, Contraindication To Medical Treatment, Haemolytic Uraemic Syndrome, Mental Disability
on Feb 09, 2010 Male patient from JAPAN , child 3 years of age, was diagnosed with haematochezia and was treated with Lopemin (View Usage). After Lopemin was administered, patient had the following side effects: condition aggravated, contraindication to medical treatment, haemolytic uraemic syndrome, mental disability. Lopemin dosage: .

6555926-X | Intestinal Obstruction, Pneumatosis Intestinalis
Patient was taking Lopemin (View Usage). Patient experienced the following unwanted or unexpected effects: intestinal obstruction, pneumatosis intestinalis on Jan 19, 2010 from JAPAN Additional patient health information: Female patient , 82 years of age, was diagnosed with diarrhoea, neoplasm malignant, enterocolitis and. Lopemin dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), ENSURE (View Ensure Review and Ensure Label ), MS CONTIN (View Ms Contin Review and Ms Contin Label ).

6534268-2 | Cholecystitis Acute, Haemoglobin Decreased
Adverse event was reported on Jan 04, 2010 by a Male patient taking Lopemin (View Usage) (Dosage: ) was diagnosed with diarrhoea, pancreatic carcinoma and. Location: JAPAN , weighting 112.4 lb, Patient had the following side effects: cholecystitis acute, haemoglobin decreased. During the same period patient was treated with TS 1 (View Ts-1 Review and Ts-1 Label ). Patient was hospitalized.

6403274-0 | Hepatic Function Abnormal
on Oct 09, 2009 Male patient from JAPAN , 68 years of age, was treated with Lopemin (View Usage). After Lopemin was administered, patient had the following side effects: hepatic function abnormal. Lopemin dosage: . During the same period patient was treated with TS 1 (View Ts-1 Review and Ts-1 Label ).

6390098-6 | Hepatic Function Abnormal
on Sep 28, 2009 Male patient from JAPAN , 68 years of age, was treated with Lopemin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. Lopemin dosage: . During the same period patient was treated with TS 1 (View Ts-1 Review and Ts-1 Label ).

6359157-8 | Eosinophilia, Hypersensitivity
Patient was taking Lopemin (View Usage). Patient had the following side effects: eosinophilia, hypersensitivity on Sep 11, 2009 from JAPAN Additional patient health information: Male patient , 60 years of age, . Lopemin dosage: . During the same period patient was treated with CAMPTOSAR (View Camptosar Review and Camptosar Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), BIFIDOBACTERIUM (View Bifidobacterium Review and Bifidobacterium Label ). Patient was hospitalized.

6256635-7 | Anuria, Dysuria, Urinary Retention
Adverse event was reported on Jul 01, 2009 by a Female patient taking Lopemin (View Usage) (Dosage: ) was diagnosed with diarrhoea and. Location: JAPAN , child 3 years of age, After Lopemin was administered, patient had the following side effects: anuria, dysuria, urinary retention.

5949662-8 | Liver Function Test Abnormal
on Nov 04, 2008 Female patient from JAPAN , 64 years of age, was diagnosed with diarrhoea, ovarian cancer and was treated with Lopemin (View Usage). Patient experienced the following unwanted or unexpected effects: liver function test abnormal. Lopemin dosage: . During the same period patient was treated with RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), MYSLEE (View Myslee Review and Myslee Label ). Patient was hospitalized.

5910630-3 | Altered State Of Consciousness, Dysphagia, Hepatic Function Abnormal, Miosis, Respiratory Failure
on Sep 30, 2008 Male patient from JAPAN , 70 years of age, was diagnosed with diarrhoea, infection (What is infection?) and was treated with Lopemin (View Usage). Patient had the following side effects: altered state of consciousness, dysphagia, hepatic function abnormal, miosis, respiratory failure. Lopemin dosage: . During the same period patient was treated with PHELLOBERIN (View Phelloberin Review and Phelloberin Label ), BIOFERMIN (View Biofermin Review and Biofermin Label ), COLONEL (View Colonel Review and Colonel Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), TIENAM (View Tienam Review and Tienam Label ).

5908267-5 | Gastric Ileus, Lower Gastrointestinal Haemorrhage, Sepsis
Patient was taking Lopemin (View Usage). After Lopemin was administered, patient had the following side effects: gastric ileus, lower gastrointestinal haemorrhage, sepsis (What is sepsis?) on Sep 23, 2008 from JAPAN Additional patient health information: Female patient , weighting 137.6 lb, was diagnosed with diarrhoea, large intestine carcinoma, pain (What is pain?), gastrointestinal mucosal disorder, nausea (What is nausea?) and. Lopemin dosage: . During the same period patient was treated with IRINOTECAN HCL (190mg/body) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), TEGAFUR/GIMERACIL/OTERACIL POTASSIUM (View Tegafur/gimeracil/oteracil Potassium Review and Tegafur/gimeracil/oteracil Potassium Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), BUSCOPAN (View Buscopan Review and Buscopan Label ), MUCOSTA (After Breakfast And Dinner) (View Mucosta Review and Mucosta Label ), VOLTAREN (After Dinner And Breakfast) (View Voltaren Review and Voltaren Label ), NOVAMIN (After Meals) (View Novamin Review and Novamin Label ). Patient was hospitalized.

5875941-9 | Liver Function Test Abnormal
Adverse event was reported on Aug 28, 2008 by a Female patient taking Lopemin (View Usage) (Dosage: ) was diagnosed with diarrhoea and. Location: JAPAN , 64 years of age, Patient experienced the following unwanted or unexpected effects: liver function test abnormal. During the same period patient was treated with ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ). Patient was hospitalized.

5675563-9 | Brain Oedema, Contraindication To Medical Treatment, Encephalopathy, Renal Failure
on Mar 11, 2008 Female patient from JAPAN , child 3 years of age, was diagnosed with haematochezia, diarrhoea and was treated with Lopemin (View Usage). Patient had the following side effects: brain oedema, contraindication to medical treatment, encephalopathy, renal failure. Lopemin dosage: . Patient was hospitalized.

5642922-X | Stevens-johnson Syndrome
on Feb 22, 2008 Male patient from JAPAN , 58 years of age, was diagnosed with diarrhoea, pyrexia, abdominal pain (What is abdominal pain?) and was treated with Lopemin (View Usage). After Lopemin was administered, patient had the following side effects: stevens-johnson syndrome. Lopemin dosage: . During the same period patient was treated with CRAVIT (View Cravit Review and Cravit Label ), LOXONIN (View Loxonin Review and Loxonin Label ), ASTOMIN (View Astomin Review and Astomin Label ), COLIOPAN (View Coliopan Review and Coliopan Label ), TRIFLUID (View Trifluid Review and Trifluid Label ).

5346150-7 | Hepatitis Acute, Jaundice, Malaise
Patient was taking Lopemin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis acute, jaundice (What is jaundice?), malaise on May 24, 2007 from JAPAN Additional patient health information: Female patient , child 9 years of age, . Lopemin dosage: . During the same period patient was treated with MUCODYNE (View Mucodyne Review and Mucodyne Label ), DASEN (View Dasen Review and Dasen Label ), ASVERIN (View Asverin Review and Asverin Label ), MIYA BM (View Miya Bm Review and Miya Bm Label ), GANATON (View Ganaton Review and Ganaton Label ), CALONAL (View Calonal Review and Calonal Label ).

5260826-1 | Myocardial Infarction, Pneumonia
Adverse event was reported on Feb 27, 2007 by a Male patient taking Lopemin (View Usage) (Dosage: ) . Location: JAPAN , 59 years of age, Patient had the following side effects: myocardial infarction, pneumonia (What is pneumonia?).

5053477-5 | Renal Impairment
on Jul 07, 2006 Male patient from JAPAN , 13 years of age, was diagnosed with diarrhoea and was treated with Lopemin (View Usage). After Lopemin was administered, patient had the following side effects: renal impairment. Lopemin dosage: In Three Divided Doses. Patient was hospitalized.

5015601-X | Cholangitis Sclerosing, Hyperglycaemia
on May 24, 2006 Male patient from JAPAN , 24 years of age, was treated with Lopemin (View Usage). Patient experienced the following unwanted or unexpected effects: cholangitis sclerosing, hyperglycaemia. Lopemin dosage: .